News for Noxopharm Limited (NOX.AX)

Published at

Feb 4, 2025 12:30 AM

by themarketherald.com.au

positive

positive

Noxopharm jumps as flagship lupus drug clears first-pass in vitro safety tests

Noxopharm has reported its lupus medication in development, SOF-SKN, has passed first-stage in vitro safety tests before clinical trials.

NOX.AX

Read more →
Published at

Sep 3, 2024 9:53 AM

by themarketherald.com.au

positive

positive

ASX Market Close: Consumer Staples dive on day of flat trading | September 3, 2024

The ASX200 closed fairly flat at 8,103 points. The Staples sector was aggressively sold down shedding 1.9%, Materials lost 1.4% and Utilities around 0.7%. On the other hand, Information Technology was the best performing sector, up 1.2%, followed closely by Financials which gained around 0.9%.

S2R.AX NOX.AX MGT.AX

Read more →
Published at

Sep 3, 2024 4:44 AM

by smallcaps.com.au

neutral

neutral

Noxopharm advances Chroma drug platform to target glioblastoma and leukaemia

Noxopharm (ASX: NOX) has made ‘substantial progress’ with its Chroma technology platform, reporting encouraging brain cancer results and early work on

NOX.AX

Read more →
Published at

Aug 19, 2024 3:36 AM

by themarketherald.com.au

positive

positive

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Noxopharm Ltd is planning the first human trial to assess novel drug SOF-SKN, which aims to treat autoimmune conditions.

NOX.AX

Read more →
Published at

Aug 14, 2024 5:47 AM

by smallcaps.com.au

negative

negative

Noxopharm reports CRO-67 breakthrough in pancreatic cancer treatment

Australian biotech company Noxopharm (ASX: NOX) has announced encouraging new data regarding the development of its CRO-67 preclinical drug for pancreatic

NOX.AX

Read more →
Published at

Sep 28, 2023 1:56 AM

by themarketherald.com.au

mixed

mixed

ASX Today: Stocks to watch on Thursday

Futures are tipping the ASX to open down this morning, following a mixed session of Wall Street and the impact of oil reaching an 11-month high.

ASN.AX AGY.AX CKA.AX NOX.AX

Read more →
Published at

Aug 7, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Acute Myeloid Leukemia Market Size and Share to Rise by 2032, Predicts DelveInsight | Key Companies - Chimerix, GlycoMimetics, Arog, Delta-Fly, Jasper, Jazz, Daiichi Sankyo, Amgen, AbbVie, Merck, Eli

The acute myeloid leukemia market has a promising outlook with emerging therapies. The overall dynamics of the acute myeloid leukemia market are...

STTK PGEN NXTC NOXOF NOX.AX MBRX LLY.MX LLY.DE LLY.BA LLY LILY34.SA KPTI IMU.DE IMGN GILDD.BA CYAD CCCC BPTH APTO APS.TO ALPMY ALPMF 4503N.MX 0QFK.L 0Q1G.L TKBIF TCON NVON.MX NVO NOVOBN.MX NOVC.DE NOVA.DE NONOF MRKR KURA INCY INAB I1NC34.SA 688336.SS 4974.T 0TDD.L 0J9P.L

Read more →
Published at

Aug 3, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Soft Tissue Sarcoma Market to Propel by 2032, Predicts DelveInsight | Key Companies in the Market - Monopar, Jazz, Tracon, C4, Eli Lilly, Epizyme, Ipsen, GlaxoSmithKline, Salarius, Merck, Agenus, Mira

The emergence of new products in the pipeline will add to the soft tissue sarcoma market growth in the future. In addition, persistently rising cases of...

NOXOF NOX.AX TKBIF TCON MRTX MBRX LLY.MX LLY.DE LLY.BA LLY LILY34.SA INCY I1NC34.SA EPZM CCCC AGEN 688336.SS 4974.T 0Q1G.L 0J9P.L SHPMY SHPMF PHIL.MI 2607.HK

Read more →
Published at

May 26, 2023 7:19 AM

by themarketherald.com.au

neutral

neutral

Noxopharm (ASX:NOX) publishes preliminary data from phase one Veyonda trial

Aussie biotech company Noxopharm (NOX) has wrapped up its IONIC investigator-initiated pilot for its oncology drug Veyonda.

NOX.AX

Read more →
Published at

May 19, 2023 2:20 AM

by themarketherald.com.au

mixed

mixed

ASX Today: Stocks to watch on Friday

The ASX is expected to open slightly higher on Friday as reports suggest the US debt ceiling talks could be resolved within the coming days.

NOX.AX IMU.AX MFB.AX GTE.AX

Read more →
Published at

May 10, 2023 5:00 PM

by prnewswire.com

mixed

mixed

Soft Tissue Sarcoma Pipeline Space Brims With Novel Emerging Therapies with Over 125 Key Companies Working in the Domain | DelveInsight

/PRNewswire/ -- DelveInsight's 'Soft Tissue Sarcoma Pipeline Insight – 2023' report provides comprehensive global coverage of available, marketed, and pipeline...

TLX.AX TLPPF TKBIF TCON SHPMY SHPMF PRRUF NOXOF NOX.AX MBRX LLY.MX LLY.DE LLY.BA LLY LILY34.SA JNJ IMMP IMM.AX DJNJ3.BA DJNJ2.BA CCCC AVCTF AVCT.L 4974.T 2607.HK 0Q1G.L INCY I1NC34.SA FHTX 688336.SS 0J9P.L LIXTW LIXT

Read more →
Published at

May 8, 2023 5:48 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

On Stockhead today, Iluka, BHP, and Barton Gold are just a few of the 15 quietly epic South Aussie miners we want to know a lot better.

WEL.AX SHL.AX RXM.AX RML.AX PIQ.AX NOXOF NOX.AX LTUM INF.AX ILU.AX HHI.AX HGO.AX CZR.AX CPH.AX CCR.AX BRK.AX BKT.AX BHP.AX AQX.AX AMD.AX AJQ.AX 0JVB.L YOJ.AX VRC.AX VMT.AX TMX.AX SEN.AX MTH.AX FYI.AX FIN.AX CLU.AX BTC.AX OAU.AX MEB.AX MDBIF KGD.AX GTG.AX GMN.AX FAU.AX ADXRF 1ST.AX

Read more →
Published at

May 8, 2023 8:55 AM

by stockhead.com.au

mixed

mixed

CLOSING BELL: Smiles all round as the ASX holds onto early gains to finish 0.78% heavier

The ASX has managed to keep hold of early gains, closing 0.78% higher as Energy and Materials (and banks) enjoy a day in the sun for a change.

WEL.AX TMX.AX SHN.AX SHL.AX RML.AX PIQ.AX NOXOF NOX.AX MSCL.SN LTUM INF.AX HHI.AX CZR.AX CXO.AX CPH.AX CCR.AX BKT.AX AQX.AX AMD.AX AJQ.AX 360.AX 0JVB.L YOJ.AX VRC.AX VMT.AX SEN.AX MTH.AX GMN.AX FYI.AX FIN.AX FAU.AX CLU.AX BTC.AX ADXRF OAU.AX MEB.AX MDBIF KGD.AX GTG.AX BRK.AX 1ST.AX

Read more →
Published at

May 8, 2023 5:34 AM

by stockhead.com.au

mixed

mixed

ASX Small Caps Lunch Wrap: Which little piggy probably wished it went to market this morning?

The ASX has kicked the week off with a bang, and Volt Resources is celebrating a strong graphite production cycle by adding 20% pre-lunch.

VRC.AX SNG.AX PACW LIN.AX IPB.AX FIN.AX CVV.AX BKT.AX AAPL RLG.AX M3M.AX KGD.AX HLX.AX COY.AX BTC.AX ADXRF VMT.AX SFG.AX RIE.AX OAU.AX NOXOF NOX.AX MTH.AX MKG.AX MEB.AX MDBIF MCM.AX LBT.AX GTG.AX GENE CLU.AX BRK.AX 1ST.AX

Read more →
Published at

May 1, 2023 9:40 PM

by stockhead.com.au

mixed

mixed

ASX April Winners: Mid and small caps outperform blue-chip peers as gold stocks keep up rally

The S&P ASX 200 gained 1.85% in April 2023, extending its YTD gain to 5.38% with mid and small caps outperforming their blue-chip peers.

WOA.AX WMG.AX TIG.AX SCU.AX RCW.AX PAB.AX ONE.AX OLL.AX IGN.AX GGE.AX FTC.AX FDMDF BPP.AX AMGRF AMA.AX 4DX.AX SM1.AX ODA.AX NXM.AX NOXOF NOX.AX MDX.AX IDT.AX ICE.AX GBE.AX G1A.AX FYI.AX EX1.AX EML.AX ELTLF ELT.AX BTC.AX AUA.AX 8VI.AX 1ST.AX NVU.AX NGY.AX LIN.AX LDR.AX KEY.AX HMX.AX CYP.AX CLT.AX BBX.AX AMD.AX 8IH.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Apr 24, 2023 5:56 AM

by stockhead.com.au

mixed

mixed

ASX Small Caps Lunch Wrap: What’s got sexy senior citizens all hot and bothered this morning?

The ASX has whip-sawed its way to a minor pre-lunch win, while Mamba's surge has continued despite yet another fall for Materials.

PVS.AX M24.AX GGX.AX FFF.AX WML.AX WMG.AX SIH.AX ROG.AX RHT.AX RGS.AX PLS.AX OSX.AX OSL.AX OAU.AX NOXOF NOX.AX MTH.AX FRM.AX DGR.AX BAT.AX YPB.AX MRQ.AX ID8.AX ICNOF ICN.AX GGE.AX FAU.AX CLE.AX BXN.AX A3D.AX

Read more →
Published at

Apr 24, 2023 2:49 AM

by stockhead.com.au

mixed

mixed

Top 10 at 10: ASX opens lower, Redstone rises on highest Cu grade ever at Tollu Copper Project

Redstone Resources announces high grade intersections at Forio including highest Cu grade ever intersected at Tollu Copper Project.

RDS.AX OAU.AX MTH.AX FFF.AX CLE.AX CHK.AX NOXOF NOX.AX ICNOF ICN.AX HLX.AX GGX.AX

Read more →
Published at

Apr 10, 2023 5:12 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

On Stockhead today, There's 14 lithium plays who now call a US mega-factory neighbour. It's Part 1 of a new Nearology series by Emma Davies.

XF1.AX WMG.AX SIT.AX SHG.AX PXXXF OZM.AX OAU.AX NWE.AX LLO.AX KNM.AX KNEOF GWR.AX GLA.AX GCY.AX EX1.AX WEL.AX SHN.AX KLL.AX CYP.AX COO.AX AXI.AX VPR.AX SFG.AX SCL.AX RIE.AX NOXOF NOX.AX AQX.AX

Read more →
Published at

Apr 6, 2023 9:22 AM

by stockhead.com.au

mixed

mixed

ASX Small Caps and IPO Weekly Wrap: Get ready for Easter, ’cause the market’s pulled a Bunny out of its hat

The ASX has ended the week up 2.25%, thanks to some pre-Easter magic from the Goldies, starring Western Mines' +166.7% belter. Happy Easter!

WMG.AX QHL.AX NSX.AX NOXOF NOX.AX MCT.AX LDR.AX FDMDF COO.AX 4DX.AX VMS.AX TD1.AX RAS.AX PUR.AX PPT.AX PAB.AX NOR.AX MME.AX HMX.AX GBE.AX ELTLF ELT.AX DXN.AX BBX.AX ARD.AX AMI.AX AD1.AX ABY.AX 8IH.AX VPR.AX TFL.AX SRJ.AX SCU.AX RNX.AX RCW.AX RBR.AX OLI.AX NWM.AX MRR.AX MIO.AX IXR.AX IGN.AX GMN.AX CYP.AX CLT.AX AYM.AX AXI.AX AVW.AX AUR.AX AQX.AX ADV.AX

Read more →